Latest
Reprogram Biosciences Raises $6M Seed to Turn Tumors Into AlliesReprogram Biosciences Raises $6M Seed to Turn Tumors Into Allies|Advaya Capital Acquires Comscore Movies and Revives RentrakAdvaya Capital Acquires Comscore Movies and Revives Rentrak|Autodesk’s $3.575B MaintainX Deal Is Really a Bet on Industrial AIAutodesk’s $3.575B MaintainX Deal Is Really a Bet on Industrial AI|Lightning Capital Management Group LLC Targets $100M for Venture Fund II as AI Moves From Novelty to InfrastructureLightning Capital Management Group LLC Targets $100M for Venture Fund II as AI Moves From Novelty to Infrastructure|Lokam.ai Raises $350K as Customer World Auto Group Becomes InvestorLokam.ai Raises $350K as Customer World Auto Group Becomes Investor|EarSmartAI Raises $250K Pre-Seed to Advance AI-Powered Pediatric Ear DiagnosticsEarSmartAI Raises $250K Pre-Seed to Advance AI-Powered Pediatric Ear Diagnostics|Apollo Bets on Apex Service Partners as Home Services Consolidation AcceleratesApollo Bets on Apex Service Partners as Home Services Consolidation Accelerates|LightTable Raises $22M Series A to Bring AI Into Construction's Most Expensive Blind SpotLightTable Raises $22M Series A to Bring AI Into Construction's Most Expensive Blind Spot|AI Risk Moves to the Boardroom at NYC Tech WeekAI Risk Moves to the Boardroom at NYC Tech Week|Why a16z, Sequence, and Thomson Bike Tours Are Bringing CFOs to Central Park During TECH WEEK NYCWhy a16z, Sequence, and Thomson Bike Tours Are Bringing CFOs to Central Park During TECH WEEK NYC|Reprogram Biosciences Raises $6M Seed to Turn Tumors Into AlliesReprogram Biosciences Raises $6M Seed to Turn Tumors Into Allies|Advaya Capital Acquires Comscore Movies and Revives RentrakAdvaya Capital Acquires Comscore Movies and Revives Rentrak|Autodesk’s $3.575B MaintainX Deal Is Really a Bet on Industrial AIAutodesk’s $3.575B MaintainX Deal Is Really a Bet on Industrial AI|Lightning Capital Management Group LLC Targets $100M for Venture Fund II as AI Moves From Novelty to InfrastructureLightning Capital Management Group LLC Targets $100M for Venture Fund II as AI Moves From Novelty to Infrastructure|Lokam.ai Raises $350K as Customer World Auto Group Becomes InvestorLokam.ai Raises $350K as Customer World Auto Group Becomes Investor|EarSmartAI Raises $250K Pre-Seed to Advance AI-Powered Pediatric Ear DiagnosticsEarSmartAI Raises $250K Pre-Seed to Advance AI-Powered Pediatric Ear Diagnostics|Apollo Bets on Apex Service Partners as Home Services Consolidation AcceleratesApollo Bets on Apex Service Partners as Home Services Consolidation Accelerates|LightTable Raises $22M Series A to Bring AI Into Construction's Most Expensive Blind SpotLightTable Raises $22M Series A to Bring AI Into Construction's Most Expensive Blind Spot|AI Risk Moves to the Boardroom at NYC Tech WeekAI Risk Moves to the Boardroom at NYC Tech Week|Why a16z, Sequence, and Thomson Bike Tours Are Bringing CFOs to Central Park During TECH WEEK NYCWhy a16z, Sequence, and Thomson Bike Tours Are Bringing CFOs to Central Park During TECH WEEK NYC
Back to articles
•

Gyde Acquires Medicare Agency Avid Health to Expand AI-Native Brokerage Platform

Most deals get announced. This one makes a point. Gyde just acquired Avid Health, and while the price tag stays offstage, the intent is loud enough to shake a sleepy category awake. You have Will Johnson and Sam Wiener building an AI-native brokerage out of Austin and New York, pulling from a $60M round led by Lightspeed Venture Partners with Optum Ventures, Crystal Venture Partners, MVP Ventures, and Virtue in the mix. Then you’ve got Gerrick Diaz, who turned Avid Health into the top-rated Medicare agency in Palm Beach by doing the unsexy thing consistently well: showing up for seniors when the system gets confusing and the stakes get personal.

Gyde isn’t rolling up agencies to strip them for parts. They’re buying signal. Avid Health brings a high-touch, education-first model in a Medicare market that eats amateurs for breakfast. Palm Beach is dense, competitive, and brutally honest about who actually delivers. Avid Health didn’t just survive there. They earned trust in a category where trust is usually buried under paperwork and hold music.

Now layer in Gyde’s angle. AI that actually works for brokers, not around them. Systems that handle the grind so advisors can stay human where it counts. The thesis is simple, but not easy: automate the noise, amplify the relationship. If you believe brokers are still the guide through one of life’s most complex decisions, then giving them better tools isn’t optional. It’s oxygen.

Andrew Shults stepping in as CTO adds another gear to that machine. This isn’t theory dressed up as product. This is operator DNA meeting infrastructure that can scale without flattening what made these agencies special in the first place.

And let’s talk timing. Medicare Advantage now covers 35.4M people, over 51% of the eligible population. The market keeps expanding, but complexity is expanding faster. Plans multiply, fine print thickens, and the average consumer is expected to make high-stakes decisions like they’re ordering lunch. That gap between complexity and clarity is where companies either fade out or print relevance.

Gyde is betting that the winners won’t be the loudest platforms or the slickest dashboards. It’ll be the ones that make brokers sharper, faster, and more present when it matters. Avid Health just became the first proof point in that play.

Congratulations to Will Johnson, Sam Wiener, Andrew Shults, and Gerrick Diaz for putting real pieces on the board. This isn’t about adding another logo to a portfolio. It’s about building a system where trust scales without losing its pulse, and where technology finally learns how to sit in the passenger seat instead of grabbing the wheel.

Related Articles

Trending

View all posts